News

The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration

August 21, 2025

The Josep Carreras Institute and the Hospital del Mar Research Institute strengthen their institutional collaboration

October 09, 2024

The impact of TP53 mutations in del5q Myelodysplastic Syndromes unveiled

October 07, 2024

An epigenetic characteristic help predict efficacy of immunotherapy in multiple myeloma

October 02, 2024

New study finds a promising combined therapy for multiple sclerosis

October 01, 2024

Described the Epigenetic Hallmarks that define Cancer

September 30, 2024

The Emerging Leaders in Biomedicine Symposium consolidated as a meeting point for the next generation of leaders in cancer research

September 27, 2024

The research project of Dr. Biola M. Javierre, from the Josep Carreras Institute, selected for the 2024 Leonardo Grants

September 25, 2024

Dr. Manel Esteller considered among the most relevant scientists worldwide according to the Stanford University

September 20, 2024

Haematological tumours are the fifth most common cancers in Spain

September 19, 2024

Low oxygen levels in tumours could enhance some of the body’s immune responses against cancer

September 18, 2024

Dr. Montse Sanchez-Cespedes receives the Fred R. Hirsch Award in Translational Medicine